Company / CapEx per Share
Relay Therapeutics, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.09
FY2021-FY2025
Trend
-84.6%
vs FY2024
Sector context
#159 of 192
Health Care
What the data says
Relay Therapeutics, Inc.'s capex per share of $0.00 is lower than 83% of companies in the Health Care sector (FY2025). Declined from $0.03 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -73.8%.
Declined from $0.03 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -48.5%
- 5-Year CAGR
- -73.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 192This company $0.00 Sector average $2.46
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 84.6% year-over-year.
- Ranks #159 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -84.6% |
| FY2024 | $0.02 | -53.5% |
| FY2023 | $0.03 | +90.9% |
| FY2022 | $0.02 | -80.0% |
| FY2021 | $0.09 | -95.5% |
| FY2020 | $1.98 | -14.5% |
| FY2019 | $2.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026